logo

For the Inventor, By the Inventor

Wauthier-Braine, Belgium

Dominique Surleraux

This inventor holds 23 USPTO granted patents and 2 published patent applications and 13 EPO patents, primarily in HCV Treatment. Top assignees: Idenix Pharmaceuticals, Inc., Centre National De La Recherche Scientifique, Université Montpellier 2 Sciences Et Techniques. Active years: 2011-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dominique Surleraux. Retrieved from https://idiyas.com/inventor/dominique-surleraux

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 82.6

 

Average Co-Inventor Count = 4.7

ph-index = 11

Forward Citations = 384(Granted Patents)


Location History:

  • Wauthier-Braine, FR (2015)
  • Wauthier-Braine, BE (2011 - 2019)

Company Filing History:

goldMedal23 out of 100 
 
Idenix Pharmaceuticals, Inc.
 patents
silverMedal4 out of 5,383 
 
Centre National De La Recherche Scientifique
 patents
bronzeMedal2 out of 37 
 
Université Montpellier 2 Sciences Et Techniques
 patents
4. 1 out of 297 
 
Universitè De Montpellier
 patents
where one patent can have more than one assignee

Years Active: 2011-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
HCV Infections
Macrocyclic Serine Protease Inhibitors
Phosphinate Ruthenium Complexes
Nucleoside Analogs
Pharmaceutical Compositions
Viral Infections
Prodrugs
Polymerase Inhibitors
Carbonyloxymethylphosphoramidate Compounds
Cyclic Phosphonates
Aryl Inhibitors
Phosphodiazine
23 patents (USPTO):Explore Patents
1. 10513534 - 2'-chloro nucleoside analogs for HCV infection (2019-12-24),
2. 9403863 - Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections (2016-08-02),
3. 9353100 - Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections (2016-05-31),
4. 9309275 - 3'-deoxy nucleosides for the treatment of HCV (2016-04-12),
5. 9296778 - 3',5′-cyclic phosphate prodrugs for HCV infection (2016-03-29),
6. 9284307 - Macrocyclic serine protease inhibitors (2016-03-15),
7. 9243025 - Compounds and pharmaceutical compositions for the treatment of viral infections (2016-01-26),
8. 9187496 - 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors (2015-11-17),
9. 9115095 - Phosphinate ruthenium complexes (2015-08-25),
10. 9109001 - 3',5′-cyclic phosphoramidate prodrugs for HCV infection (2015-08-18),
11. 8993595 - Macrocyclic serine protease inhibitors (2015-03-31),
12. 8951985 - Compounds and pharmaceutical compositions for the treatment of viral infections (2015-02-10),
13. 8765966 - Phosphinate ruthenium complexes (2014-07-01),
14. 8680071 - Compounds and pharmaceutical compositions for the treatment of viral infections (2014-03-25),
15. 8507460 - Substituted 3',5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections (2013-08-13),

Title: Inventor Dominique Surleraux: Pioneering Innovations in Wauthier-Braine, BE

Introduction: Dominique Surleraux is a renowned inventor hailing from Wauthier-Braine, Belgium, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Dominique Surleraux holds several patents in the areas of telecommunications, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Dominique Surleraux has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible in the world of inventions.

Collaborations: Throughout his career, Dominique Surleraux has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence that has led to numerous successful inventions and patents.

Conclusion: Dominique Surleraux's passion for innovation and his relentless drive to create solutions for the future make him a true pioneer in the world of inventors, leaving a lasting impact on the industry and inspiring generations to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…